Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Kennedy, who suspended his independent bid for the presidency to endorse Trump immediately following the Democratic National ...

In sixty years of career, he spoke about racism, religion, sex, hunger, death penalty, war, anorexia, violence. The ...

McKinsey & Company’s prestigious two-day workshop Bower Forum is a unique platform for a small group of CEOs or Chairpersons ...

Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...

Moderna made a lot of money during the pandemic, but its post-pandemic prospects look bleak. Sales in 2025 could be down more than half from 2024 levels, according to Moderna's latest guidance ...

Earlier this month, Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s lackluster vaccine sales in COVID-19 and respiratory ...

Moderna projects $1.5 billion-$2.5 billion in 2025 revenue, with cash and investments estimated at $6 billion by year-end. 2024 product sales are approximately $3 billion-$3.1 billion, driven by $ ...

An unprecedented influenza surge in Minnesota has sent thousands of sick patients to the hospital in recent weeks, with 50 ...

Drug maker Moderna's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion. The company reported product sales of $3 to $3.1 billion ...